跳至主要内容
临床试验/NCT02661776
NCT02661776已完成不适用

The Change of NK Cell Activity After Head and Neck Cancer Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2016年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
1
主要终点
The change of NK cell activity

研究概览

简要总结

Cellular immunity can be changed after surgery and anesthesia. Tissue injury by surgical procedures significantly reduces the immune function in proportion to the degree of tissue injury. In addition, the use of opioids as analgesics during the perioperative period depress cellular immunity, in particular the activity of the natural killer (NK) cells. This perioperative immunosuppression may cause deleterious consequences on postoperative outcome in cancer patients. The aim of this study is to confirm the presence or extent of the change of NK cell activity between before and after head and neck surgery. Additionally, investigators will identify the clinical or genetic factors related to the change of NK cell activity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patients undergoing head and neck surgery including tumor removal and reconstruction with flap

排除标准

  • patients refusal
  • patients not able to read, or understand the consent form
  • History of Active viral or bacterial infection
  • History of use of immunosuppressive drugs within the last six months
  • History of chemotherapy
  • History of autoimmune disorders
  • Known HIV, Hepatitis B, or Hepatitis C infection
  • Female who is pregnant, nursing
  • ethnicity, other than asian

结局指标

主要结局

The change of NK cell activity

时间窗: 24 hours

Preoperative NK cell activity will be measured using the NK vue diagnostic test before surgery and anesthesia. Postoperative NK cell activity will be measured using the NK vue diagnostic test after 24 hours since stopping the use of intravenous remifentanil as analgesics during anesthesia in the operating room or sedation in the intensive care unit.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验